The in vitro experiments showed that the downregulation of the FOXD3 gene could inhibit the apoptosis of colon cancer bone metastases, enhance the invasion ability of cells, and significantly increase the proliferation of cells. The gene discussed is FOXD3; the disease is colonic neoplasm.